Cardio Diagnostics Holdings, Inc. (CDIO) income statement
CDIONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIOW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30
$1.71−0.08 (-4.47%)
Close on Nov 17, 2026Market cap $5.06MP/E –Yield –
Cardio Diagnostics Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -43737.5%
- Net margin
- -43832.5%
- Return on equity, FY2025
- -78.6%
Financial strength
- Current ratio
- 17.15
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 0.0%
Valuation
- P/E ratio
- –
- Price to sales
- 341.36
- Price to book
- 0.68
- Dividend yield
- –
See a number that looks wrong?